Overview Fundamentals API Earnings EOD API Sample Code Pricing

enGene Holdings Inc. Warrants (ENGNW NASDAQ) stock market data APIs

$1.35 -0.1(-6.9%) as of July 26, 2024
Price chart is built with Anychart

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

enGene Holdings Inc. Warrants Financial Data Overview

1.45
1.35
-
1.45
1.35
0.391-6.5
0
0
0
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ENGNW',
Type: 'Common Stock',
Name: 'enGene Holdings Inc. Warrants',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG01J3GCZQ9',
ISIN: NULL,
CUSIP: NULL,
CIK: '1980845',
EmployerIdNumber: NULL,
FiscalYearEnd: 'October',
IPODate: '2023-11-01',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

enGene Holdings Inc. Warrants Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get enGene Holdings Inc. Warrants Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get enGene Holdings Inc. Warrants End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com